- GlobeNewswire•10 days agoOpiant Pharmaceuticals to Present at the Rodman & Renshaw Conference on September 13 in New York City
SANTA MONICA, Calif., Aug. 18, 2016-- Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders, will present ...
- Accesswire•13 days ago
NEW YORK, NY / ACCESSWIRE / August 15, 2016 / If you took NIH funding and got a drug approved by the FDA in the last 3 years, you are part of an elite group of 4 small-cap publicly-traded biotech names ...
- The Wall Street Journal•last month
The company’s main products, the Dash and Dot robots, teach children computer science and coding fundamentals.
Opiant Pharmaceuticals, Inc. (OPNT)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||7.38 - 7.60|
|52wk Range||7.15 - 7.60|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.66|
|Avg Vol (3m)||4,375|
|Dividend & Yield||N/A (N/A)|